{
    "id": 1723,
    "fullName": "CDKN1A dec exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "CDKN1A dec exp indicates decreased expression of the Cdkn1a protein and/or mRNA. However, the mechanism causing the decreased expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 1026,
        "geneSymbol": "CDKN1A",
        "terms": [
            "CDKN1A",
            "CAP20",
            "CDKN1",
            "CIP1",
            "MDA-6",
            "P21",
            "p21CIP1",
            "SDI1",
            "WAF1"
        ]
    },
    "variant": "dec exp",
    "createDate": "09/16/2014",
    "updateDate": "12/19/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1008,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, breast cancer cell lines with decreased Cdkn1a expression and loss of Tp53 function were more sensitive to AMG 900 in culture (PMID: 24091768).",
            "molecularProfile": {
                "id": 1705,
                "profileName": "CDKN1A dec exp TP53 inact mut"
            },
            "therapy": {
                "id": 983,
                "therapyName": "AMG 900",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 725,
                    "pubMedId": 24091768,
                    "title": "AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24091768"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1704,
            "profileName": "CDKN1A dec exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 1705,
            "profileName": "CDKN1A dec exp TP53 inact mut",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}